According to a comprehensive market report authored by DeciBio Consulting LLC, "In Vitro Diagnostic (IVD) Market Report 2025-2030", the global in vitro diagnostics market is predicted to reach $109B ...
DUBLIN--(BUSINESS WIRE)--The "IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering Technology, Application - Global Forecast to 2031" report has been added to ...
Zacks Investment Research on MSN
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI TEM has been putting in efforts to solidify its position in the genomics space. In September 2025, the company received FDA 510(k) clearance for its xR IVD to support life sciences drug ...
Register for our upcoming webinar “Accelerate your IVD assay development with the unique support of the Dynabeads team” and learn how Dynabeads technology and commercial partnership can help ...
The future depends on collaboration between pharma and diagnostics companies to implement strategies that accelerate innovation, ensure regulatory alignment, and deliver local access at global scale ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a ...
IVD Medical Holding Limited ( ($HK:1931) ) has shared an update. IVD Medical Holding Limited has announced that it is in discussions to ...
In a surprise reveal that propelled stocks by 25%, Alteogen Inc., of Daejeon, South Korea, named MSD International Business GmbH as its counterpart in a near-$4... Amid intensifying competition in the ...
GENCURIX signs as inaugural partner to develop multiplex oncology assays for tissue and liquid biopsies Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback